GLP-1 RAs may reduce adverse effects in morbidly obese TKA patients: Study Jacinthlyn Sylvia12 Jan 2025 8:15 PM ISTA new study published in The Journal of Bone and Joint Surgery showed that when glucagon-like peptide-1 receptor agonist (GLP-1 RAs) are used during...
Exercise combined with GLP-1RA outperforms liraglutide alone in Optimizing weight loss and bone health: JAMA Medha Baranwal2 July 2024 10:00 AM ISTDenmark: A recent secondary analysis of a randomized clinical trial including 195 adults with obesity has provided valuable insights into the impact...
Phentermine Shows Promise in Enhancing Weight Loss for Patients Discontinuing GLP-1s: Study Medha Baranwal25 Jun 2024 9:45 AM ISTUSA: In the realm of weight management, the quest for effective strategies continues to evolve, with recent findings shedding light on promising...
Mazdutide promising GLP-1 and glucagon receptor dual agonist for treating type 2 diabetes: Phase 2 trial Medha Baranwal18 Jan 2024 6:00 AM ISTChina: Findings from a Phase 2 trial have shown an improvement in weight loss and glycemic control with mazdutide use in patients with type 2...
Semaglutide, both oral and subcutaneous, significantly reduces systolic BP in diabetes patients Medha Baranwal3 Jan 2024 10:00 PM ISTChina: A recent systematic review and meta-analysis showed a significant reduction in systolic blood pressure (SBP) with oral or subcutaneous...
Tirzepatide bests Prandial Insulin as add-on option to basal Insulin for improving glycemic control among diabetics Dr. Kamal Kant Kohli5 Nov 2023 8:00 PM ISTA recent study reveals tirzepatide as a highly effective and safer alternative to prandial insulin for individuals with type 2 diabetes inadequately...
Oral diabetes drug Danuglipron achieves similar weight loss as Ozempic injection: JAMA Medha Baranwal24 May 2023 11:15 AM ISTUSA: Danuglipron demonstrated a safety and efficacy profile in tune with peptidic glucagon-like peptide 1 receptor agonists in type 2 diabetes (T2D)...
GLP-1 RAs not associated with arrhythmia risk and impart positive cardiovascular safety Jacinthlyn Sylvia9 Jan 2023 9:30 AM ISTA new study by Sijin Wu and team shows that the use of Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) did not increase arrhythmia risk,...
GLP 1 receptor agonist superior in lowering glucose in diabetes patients treated with insulin Aditi5 Jan 2023 10:15 AM ISTTaiwan: According to a study published in the Pharmaceuticals, Glucagon-like peptide 1 receptor agonists (GLP-1 RA) have superiority in lowering...
DPP4i and GLP1Ra as effective as insulin for in-hospital management of diabetes: Study Medha Baranwal12 Aug 2022 12:45 PM ISTColombia: Inpatient management of type 2 diabetes patients in the general ward with GLP1Ra and DPP4i is equally safe and effective compared to insulin...
Diabetes drug lowers glaucoma risk along with blood sugar control in diabetics: Study Hina Zahid22 Sept 2021 9:15 AM ISTPHILADELPHIA - Glucagon-like peptide-1 receptor (GLP-1R) agonists is a popular class of diabetes medications that regulate blood sugar and are...
